Vol 67 No 02

February 10, 2022

Take steps to ensure a positive first and lasting impression.

February 09, 2022

Experts evaluate 3 clinical scenarios and determine the appropriate course of action.

February 04, 2022

Risk assessment, lifestyle counseling, adverse effects, and medication management.

February 04, 2022

Understanding the technology behind a newer uterus-sparing option for the management of uterine fibroids.

February 03, 2022

Protocol 5 - In this protocol, Norton reviews the pathophysiology of fetal aneuploidy and the wide range of tests for it. Included are perspectives on cell-free DNA testing, first-trimester combined screening, nuchal translucency (NT) sonography, and pregnancy-associated plasma protein A (PAPP-A) and human chorionic gonadotropin (hCG), as well as quad marker screening in the second trimester in appropriate cases, and combined first- and second-trimester screening.

February 02, 2022

American Heart Month serves as a reminder for health care providers to not only provide the best care possible to their patients but also prioritize their own health.

February 02, 2022

For more than 70 years, vaccination has been a public health strategy for disease mitigation. Even in populations often considered “vulnerable”—children and pregnant women—vaccination is strongly recommended and commonly embraced.

January 14, 2022

Half of prisons and over 80% of jails in the United States allowed postpartum permanent contraception, according to a study in the journal Contraception.

December 09, 2021

A recent study found ibrexafungerp (Brexafemme, Scynexis) was found to be a well-tolerated novel antifungal with similar efficacy to fluconazole for treating acute vulvovaginal candidiasis.

December 02, 2021

Midlife women with early-stage vision impairment are significantly more likely to develop depressive symptoms, according to a study in the journal Menopause, which used data from the Michigan site of the Study of Women’s Health Across the Nation (SWAN).

November 15, 2021

“If you want to provide comprehensive care, it is truly impossible as 1 person,” began Jean Uy-Kroh, MD, FACOG, director, Chronic Pelvic Pain Program at the Cleveland Clinic in Cleveland, Ohio, at AAGL’s 50th Global Congress on MIGS in Austin, Texas.